These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31507529)

  • 1. Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Liu XD; Bao Y; Liu GJ
    Front Neurol; 2019; 10():934. PubMed ID: 31507529
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced therapies in Parkinson's disease: Long-term retrospective study.
    Merola A; Espay AJ; Romagnolo A; Bernardini A; Rizzi L; Rosso M; Espay KJ; Zibetti M; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2016 Aug; 29():104-8. PubMed ID: 27215392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation.
    Fernández-Rodríguez B; Dupouy J; Harroch E; Fabre-Delcros MH; Barthélémy C; Loubière P; Barange K; Brefel-Courbon C; Rascol O; Ory-Magne F
    Rev Neurol (Paris); 2021 Oct; 177(8):919-923. PubMed ID: 34154827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching and Combining Device-Aided Therapies in Advanced Parkinson's Disease: A Double Centre Retrospective Study.
    Georgiev D; Delalić S; Zupančič Križnar N; Socher A; Gurevich T; Trošt M
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Wang L; Li J; Chen J
    Front Neurol; 2018; 9():620. PubMed ID: 30104997
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
    Antonini A; Pahwa R; Odin P; Isaacson SH; Merola A; Wang L; Kandukuri PL; Alobaidi A; Yan CH; Bao Y; Zadikoff C; Parra JC; Bergmann L; Chaudhuri KR
    CNS Drugs; 2022 Dec; 36(12):1269-1283. PubMed ID: 36414908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease.
    Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC
    Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation.
    Elkouzi A; Ramirez-Zamora A; Zeilman P; Barabas M; Eisinger RS; Malaty IA; Okun MS; Almeida L
    Ann Clin Transl Neurol; 2019 Oct; 6(10):1989-1995. PubMed ID: 31518070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preference of device-based treatment of Parkinson's disease.
    Aydemir ST; Kumcu MK; Ulukan Ç; Bakirarar B; Akbostancı MC
    Int J Neurosci; 2022 Sep; 132(9):925-929. PubMed ID: 33208012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
    Pålhagen SE; Sydow O; Johansson A; Nyholm D; Holmberg B; Widner H; Dizdar N; Linder J; Hauge T; Jansson R; Bergmann L; Kjellander S; Marshall TS
    Parkinsonism Relat Disord; 2016 Aug; 29():17-23. PubMed ID: 27318707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.
    Lopiano L; Modugno N; Marano P; Sensi M; Meco G; Solla P; Gusmaroli G; Tamma F; Mancini F; Quatrale R; Zangaglia R; Bentivoglio A; Eleopra R; Gualberti G; Melzi G; Antonini A
    J Neurol; 2019 Sep; 266(9):2164-2176. PubMed ID: 31134377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review.
    Sheshadri V; Rowland NC; Mehta J; Englesakis M; Manninen P; Venkatraghavan L
    Can J Neurol Sci; 2017 Nov; 44(6):697-704. PubMed ID: 28920562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials.
    Xu F; Ma W; Huang Y; Qiu Z; Sun L
    Neuropsychiatr Dis Treat; 2016; 12():1435-44. PubMed ID: 27382286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.